Skip to main content
. 2014 Jun;52(6):2096–2099. doi: 10.1128/JCM.00228-14

TABLE 2.

Rates of antimicrobial nonsusceptibility of serogroup 6 isolates

Antimicrobial agent No. (%) of nonsusceptible isolatesa
Serogroup 6 (n = 147) Serotype 6A (n = 64) Serotype 6B (n = 34) Serotype 6C (n = 6) Serotype 6D (n = 19) Putative serotype 6E (n = 24)
Penicillin 3 (2.0) 2 (3.1) 1 (2.9) 0 0 0
Amoxicillin 4 (2.7) 0 2 (5.9) 0 0 2 (8.3)
Amoxicillin-clavulanate 4 (2.7) 0 2 (5.9) 0 0 2 (8.3)
Ceftriaxone 3 (2.0) 2 (3.1) 1 (2.9) 0 0 0
Cefuroxime 129 (87.8) 60 (93.8) 28 (82.4) 2 (33.3) 16 (84.2) 23 (95.8)
Erythromycin 137 (93.2) 63 (98.4) 34 (100) 3 (50.0) 17 (89.5) 20 (83.3)
Azithromycin 129 (87.8) 57 (89.1) 34 (100) 3 (50.0) 13 (68.4) 22 (91.7)
Clarithromycin 135 (91.8) 60 (93.8) 34 (100) 3 (50.0) 15 (78.9) 23 (95.8)
Levofloxacin 8 (5.4) 1 (1.6) 1 (2.9) 0 5 (26.4) 1 (4.2)
Moxifloxacin 2 (1.4) 1 (1.6) 1 (2.9) 0 0 0
Gatifloxacin 8 (5.4) 1 (1.6) 1 (2.9) 0 5 (26.4) 1 (4.2)
Clindamycin 101 (68.7) 44 (68.8) 32 (94.1) 3 (50.0) 5 (26.4) 17 (70.8)
Trimethoprim-sulfamethoxazole 124 (84.4) 55 (85.9) 34 (100) 3 (50.0) 8 (42.1) 24 (100)
a

The MIC nonsusceptibility breakpoints of the antimicrobial agents are as follows: penicillin, 4 mg/liter; amoxicillin, 4 mg/liter; amoxicillin-clavulanate, 4/2 mg/liter; ceftriaxone, 2 mg/liter; cefuroxime, 1 mg/liter; erythromycin, 0.5 mg/liter; azithromycin, 1 mg/liter; clarithromycin, 0.5 mg/liter; levofloxacin, 4 mg/liter; moxifloxacin, 2 mg/liter; gatifloxacin, 2 mg/liter; clindamycin; 0.5 mg/liter; trimethoprim-sulfamethoxazole, 1/19 mg/liter.